ATC code A05: Difference between revisions
m 1 revision imported |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 38: | Line 38: | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:ATC codes|A05]] | [[Category:ATC codes|A05]] | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 02:55, 17 March 2025
| ATC codes |
|---|
| A Alimentary tract and metabolism |
| A01 Stomatological preparations |
| A02 Drugs for acid related disorders |
| A03 Drugs for functional gastrointestinal disorders |
| A04 Antiemetics and antinauseants |
| A05 Bile and liver therapy |
| A06 Drugs for constipation |
| A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents |
| A08 Antiobesity preparations, excluding diet products |
| A09 Digestives, including enzymes |
| A10 Drugs used in diabetes |
| A11 Vitamins |
| A12 Mineral supplements |
| A13 Tonics |
| A14 Anabolic agents for systemic use |
| A15 Appetite stimulants |
| A16 Other alimentary tract and metabolism products |
|
A
B
C
D
G
H
QI
J
L
M
N
P
R
S
V
|
ATC code A05 Bile and liver therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.<ref>
ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.
</ref><ref>
ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.
</ref> Subgroup A05 is part of the anatomical group A Alimentary tract and metabolism.<ref>
ATC/DDD Index 2022
- code A05(link).
{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.
</ref>
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA05.<ref>
ATCvet Index 2022
- code QA05(link).
{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.
</ref> ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
A05A Bile therapy[edit]
A05AA Bile acids and derivatives[edit]
- A05AA01 Chenodeoxycholic acid
- A05AA02 Ursodeoxycholic acid
- A05AA03 Cholic acid
- A05AA04 Obeticholic acid
A05AB Preparations for biliary tract therapy[edit]
- A05AB01 Nicotinyl methylamide
A05AX Other drugs for bile therapy[edit]
- A05AX01 Piprozolin
- A05AX02 Hymecromone
- A05AX03 Cyclobutyrol
- QA05AX90 Menbutone
A05B Liver therapy, lipotropics[edit]
A05BA Liver therapy[edit]
- A05BA01 Arginine glutamate
- A05BA03 Silymarin
- A05BA04 Citiolone
- A05BA05 Epomediol
- A05BA06 Ornithine oxoglutarate
- A05BA07 Tidiacic arginine
- A05BA08 Glycyrrhizic acid (glycyrrhizin)
- QA05BA90 Methionine
A05C Drugs for bile therapy and lipotropics in combination[edit]
- Empty group
References[edit]
<references group="" responsive="1"></references>
| Bile and liver therapy (A05) | ||||
|---|---|---|---|---|
|